LIBTAYO

Mfd. by :- Sanofi (Fulfilled By : Magicine Pharma)

Libtayo

SAFE AND SECURE


Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.

Check Availability in your country

GLOBAL SUPPLY

Similar Products

  • Tripocine..
  • Libtayo ..
  • Maball..
  • Stivarga..
  • Capetero..
  • Fulvant..

DESCRIPTION

  • :
  • :
  • :
  • :
  • :

PACKAGE

Don't have Prescription ?

Brand Name:- Libtayo 

Generic Name:- Cemiplimab-rwlc

Manufacturer:- Sanofi 

Dosage:- Injection 

Strength:- 350mg/7ml (50mg/ml)

Composition:- Cemiplimab-rwlc

Packaging:- 1vial

Indication:- Skin Cancer

Storage:- Store at room temperature 

Overview 

Libtayo (Cemiplimab-rwlc) is used to treat a type of skin cancer that has spread to other areas of the body that cannot be treated with radiation or surgery. It is given as an infusion into the vein. Do not self administer this medicine. Take this medicine as prescribed by your medical advisor. Your doctor will decide the exact dosage. Do not take this medicine in the wrong way as it may lead to some severe side effects. It is advisable not to change or stop the dose without taking suggestions from your doctor. If you experience any symptoms while receiving this medicine, inform your doctor immediately.  

Pharmacodynamics of Libtayo

Cemiplimab inhibits tumor growth by an immune-mediated mechanism, specifically by the inhibition of the programmed death receptor 1 (PD-1) treating cutaneous squamous cell carcinoma. 350mg IV over 30 minutes every 3 weeks until disease progression.

Side effects of Libtayo

This medicine may cause some serious and unwanted side effects. It requires immediate medical attention otherwise it can also lead to higher risk. Discuss the risks and benefits of this medication with a medical advisor before starting the treatment. 

Common side effects 

  • Diarrhea 

  • Fever 

  • Cough 

  • Itching 

  • Abdominal pain 

  • Dizziness 

  • Sore throat 

  • Headache 

  • Nausea 

  • Vomiting 

  • Skin rash 

  • Blurred vision

  • Difficulty in urination 

  • Pale skin 

  • Anxiety 

  • Fainting 

  • Muscle pain 

  • Constipation 

  • Bleeding 

  • Irregular heartbeat 

  • Allergic reaction 

  • Chest pain 

  • Seizures 

  • Pounding in the ears 

  • Facial swelling 

  • Back or neck pain 

  • Anemia 

  • Change in eyesight 

  • Swollen glands 

  • Swelling in your ankles 

  • Tingling of arms and legs 

  • Skin blistering 

Note- Immediately contact your doctor if side effects occur.

Dosage

Take this injection as prescribed by your doctor. Do not self administer.  The injection is given as an infusion into your vein by a doctor or nurse. 

 

Missed dose 

  •  It is advisable not to miss a dose. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately. 

Overdose 

  • In case of an overdose, the doctor will provide emergency medical treatment.

Usage of Libtayo 

This medicine is used to treat a certain type of cancer (cutaneous squamous cell carcinoma) CSCC. This medication works by changing the action of the immune system and directing it to kill or stops the growth of cancer cells. Take this medicine according to your dosing schedule. This medicine must be given slowly, it takes at least 30 minutes to complete one infusion. The dose of medicine is decided by a medical advisor according to your response to the treatment and your previous medical condition. Cemiplimab is given once every 3 weeks. This medicine is not recommended for breastfeeding. Protect this medicine from heat and light. Do not shake or freeze the medicine. 

Warnings

Before starting treatment with Libtayo, please inform your doctor about your previous medical history. If you experience any symptoms while receiving this medication, do not ignore those symptoms because it may lead to higher risk. 

  •  Contraception 

    • Use effective methods of contraception to prevent pregnancy while taking this medicine. 

  • Children and adolescents 

    • This medicine is not advisable for use in children and adolescents. 

Warnings for female 

  • Pregnancy 

    • Libtayo shouldn’t be used by pregnant women. Cemiplimab-rwlc may cause harm to the baby. It is recommended that this medicine should be avoided during pregnancy. 

  • Breastfeeding 

    • This medicine is not recommended in breastfeeding unless it is necessary. Please consult your medical advisor before starting treatment with this medication.

General warning and precautions 

  • Do not receive any vaccine during your treatment with this medicine. 

  • This medicine may cause immune-related problems. 

  • A regular blood test is required to check the side effects. 

  • Do not breastfeed while taking cemiplimab.

  • Avoid contact with people who have infections.

  • Libtayo can immune-mediated thyroid disorders. 

Cautions

  • Not safe for pregnant women. 

  • Do not drive or operate heavy machinery. 

  • Do not self administer this medicine.

  • Do not breastfeed while receiving this medication.

Q1. What is Libtayo (Cemiplimab-rwlc)? 

Ans. Libtayo (Cemiplimab-rwlc) is used to treat a certain type of skin cancer that has spread to other parts of the body or cannot be treated with radiation or surgery. 

Q2. How does Libtayo (Cemiplimab-rwlc) work?

Ans. This medication works by changing the action of the immune system and directing it to kill or stop the growth of cancer cells. This medicine belongs to a class of drugs known as monoclonal antibodies. 

Q3. In what strength is it available? 

Ans. This medicine is available in the strength of 350mg/7ml (50mg/ml). 

Q4. What are the common side effects? 

Ans. Some common side effects are:- diarrhea, nausea, constipation, sore throat, fever, cough, skin rash, abdominal pain, pale skin, chest pain, irregular heartbeat, blurred vision, etc. 

Q5. How is Libtayo given? 

Ans. This medicine is given as an infusion into the vein. It is given once every 3 weeks. The infusion usually takes 30 minutes to complete. 

Q6. What should I avoid while receiving this medication? 

Ans. Follow your doctor’s instructions about any restrictions on food or physical activities. 

Q7. What happens if I miss a dose? 

Ans. If you miss a scheduled dose of this medicine, contact your doctor immediately. 

Q8. What are the self-care tips? 

Ans. Keep yourself hydrated and maintain good nutrition. 

Q9. Can I consume alcohol while taking this medicine? 

Ans. It is not known whether it is safe or not. Please consult your doctor before consuming alcohol. 

Q10. Can I drive after taking this medicine? 

Ans. This medicine may decrease your ability to drive or affect your vision. Do not drive if any symptoms occur. 

Q11. Does this affect kidney function? 

Ans. Please consult your doctor, before consuming this drug. 

Q12. Can I take this medicine during pregnancy?

Ans. This medicine is not recommended for pregnant women. 

Q13. Can I take this medicine during breastfeeding? 

Ans.  This medicine is not recommended in breastfeeding unless it is necessary.

Q14. What are the storage conditions? 

Ans. Store this medicine at room temperature. Do not shake or freeze the medicine.

Interactions

Interactions may change how your medication works and increase the risk for side effects. Don’t forget to disclose your previous medical history with the doctor. 

Medicine interactions 

  • Cortisone 

  • Prednisolone 

  • Deflazacort 

  • Hydrocortisone 

  • Budesonide 

Disease interaction 

  • Hepatic impairment 

  • Renal dysfunction 

Alcohol interaction

  • Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol. 

Contraindications

  • Libtayo injection is not recommended for use in patients with a known allergy to Cemiplimab-rwlc.  

  • This medicine is contracted in patients known to be hypersensitive.

Above Content has been reviewed by Professionals